In Brief: Pharmacia & Upjohn
Executive Summary
Pharmacia & Upjohn: Company acquires U.S. marketing rights to anti-migraine therapy almotriptan from Spanish firm Almirall Prodesfarma. P&U plans to file an NDA for almotriptan by end of 1998...
Pharmacia & Upjohn: Company acquires U.S. marketing rights to anti-migraine therapy almotriptan from Spanish firm Almirall Prodesfarma. P&U plans to file an NDA for almotriptan by end of 1998.... |